Access to affordable medicines: obligations of universities and academic medical centers
Gene Ther
.
2023 Nov;30(10-11):753-755.
doi: 10.1038/s41434-023-00393-2.
Epub 2023 Nov 8.
Authors
Steven Joffe
1
2
,
Rena M Conti
3
,
Jorge L Contreras
4
,
Emily A Largent
5
6
,
Holly Fernandez Lynch
5
6
,
David Mitchell
7
,
Rachel E Sachs
8
,
Allison M Whelan
9
,
Matthew S McCoy
5
6
Affiliations
1
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
[email protected]
.
2
Leonard Davis Institute for Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
[email protected]
.
3
Department of Markets, Public Policy and Law, Questrom School of Business, Boston University, Boston, MA, USA.
4
S.J. Quinney College of Law, University of Utah, Salt Lake City, UT, USA.
5
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
6
Leonard Davis Institute for Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
7
Patients for Affordable Drugs, Washington, DC, USA.
8
Washington University School of Law, St. Louis, MO, USA.
9
Georgia State University College of Law, Atlanta, GA, USA.
PMID:
37935851
DOI:
10.1038/s41434-023-00393-2
No abstract available
Publication types
Review
Research Support, N.I.H., Extramural
MeSH terms
Academic Medical Centers*
Costs and Cost Analysis
Universities
Grants and funding
UL1 TR001878/TR/NCATS NIH HHS/United States